Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population

(2012) Maria Stepanova et al.   Clinical Gastroenterology and Hepatology

Potential mechanisms underlying the associations between liver enzymes and risk for type 2 diabetes

(2012) Chapy Venkatesan et al.   HEPATOLOGY

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not

(2012) Zobair M. Younossi et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008

(2011) Zobair M. Younossi et al.   Clinical Gastroenterology and Hepatology

Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality

(2011) Zobair M. Younossi et al.   HEPATOLOGY

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

(2010) Giovanni Musso et al.   ANNALS OF MEDICINE

Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study

(2010) M. Stepanova et al.   GUT

Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease

(2010) Giovanni Targher et al.   HEPATOLOGY

Prevalence, gender, ethnic variations, and prognosis of NASH

(2010) Etsuko Hashimoto et al.   JOURNAL OF GASTROENTEROLOGY

A fresh look at NASH pathogenesis. Part 1: The metabolic movers

(2010) Claire Z Larter et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity

(2010) Anna Ludovica Fracanzani et al.   JOURNAL OF HEPATOLOGY

Review: Treatment options for nonalcoholic fatty liver disease

(2010) Brian Lam et al.   Therapeutic Advances in Gastroenterology

Role of Insulin Resistance and Lipotoxicity in Non-Alcoholic Steatohepatitis

(2009) Kenneth Cusi   Clinics in Liver Disease

Nonalcoholic Fatty Liver Disease: A Practical Approach to Evaluation and Management

(2009) Nila Rafiq et al.   Clinics in Liver Disease

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up

(2009) Cecilia Söderberg et al.   HEPATOLOGY

Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study

(2008) Winston Dunn et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver

(2008) Nila Rafiq et al.   Clinical Gastroenterology and Hepatology

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

(2008) G. Targher et al.   DIABETOLOGIA

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

(2008) Anna Ludovica Fracanzani et al.   HEPATOLOGY

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease

(2008) Janus P. Ong et al.   JOURNAL OF HEPATOLOGY

The role of fatty acids in the development and progression of nonalcoholic fatty liver disease

(2008) Christopher L. Gentile et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Effects of Weight Loss on Nonalcoholic Fatty Liver Disease

(2008) Nila Rafiq et al.   SEMINARS IN LIVER DISEASE